Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Gastrointestinal neoplasms

Gastrointestinal neoplasms

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Gastrointestinal neoplasms

7 trials tracked for Gastrointestinal neoplasms.

7Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Phase 1 1 Other / NA 3
  1. Phase 2 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Completed
  2. Phase 2 Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) Completed
  3. Phase 2 A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer Completed
  4. Phase 1 A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer Completed
  5. N/A Cerebral Blood Flow During Propofol Anaesthesia Completed
  6. N/A Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers Completed
Show 1 more trials
  1. N/A Evaluating Strategies to Present Colon Cancer Screening Information Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Robotic-assisted endoscopic submucosal dissection achieves 98.2% en-bloc and 96.8% R0 resection rates in GI neoplasms
Oncology Meta-analysis
Robotic-assisted endoscopic submucosal dissection achieves 98.2% en-bloc and 96.8% R0 resection rates in GI neoplasms Robotic surgery shows high success for removing gastrointestinal tumors
This Bayesian single-arm meta-analysis of 183 lesions indicates that robotic-assisted endoscopic submucosal dissection (R-ESD) achieves high…
Robotic-assisted surgery shows high success rates for removing gastrointestinal tumors, though more large-scale studies are needed to confir…
Sep 1, 2026